A detailed history of British Columbia Investment Management Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 3,324 shares of BIO stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,324
Previous 3,812 12.8%
Holding current value
$1.14 Million
Previous $1.04 Million 6.82%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $128,817 - $168,184
-488 Reduced 12.8%
3,324 $1.11 Million
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $336,934 - $426,386
1,256 Added 49.14%
3,812 $1.04 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $20,983 - $24,287
69 Added 2.77%
2,556 $884,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $128,489 - $174,124
477 Added 23.73%
2,487 $803,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $13,309 - $16,059
38 Added 1.93%
2,010 $720,000
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $1,256 - $1,509
-3 Reduced 0.15%
1,972 $944,000
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $76,672 - $99,410
-218 Reduced 9.94%
1,975 $830,000
Q3 2022

Nov 10, 2022

SELL
$412.59 - $563.26 $162,147 - $221,361
-393 Reduced 15.2%
2,193 $915,000
Q2 2022

Aug 12, 2022

SELL
$463.67 - $597.16 $401,074 - $516,543
-865 Reduced 25.07%
2,586 $1.28 Million
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $236,581 - $331,674
-451 Reduced 11.56%
3,451 $1.94 Million
Q4 2021

Feb 11, 2022

SELL
$708.84 - $794.68 $153,109 - $171,650
-216 Reduced 5.25%
3,902 $2.95 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $1,973 - $2,477
-3 Reduced 0.07%
4,118 $3.07 Million
Q2 2021

Aug 09, 2021

BUY
$576.64 - $649.04 $273,904 - $308,294
475 Added 13.03%
4,121 $2.66 Million
Q1 2021

Apr 30, 2021

SELL
$547.01 - $662.35 $50,324 - $60,936
-92 Reduced 2.46%
3,646 $2.08 Million
Q4 2020

Feb 02, 2021

SELL
$510.68 - $643.45 $49,025 - $61,771
-96 Reduced 2.5%
3,738 $2.18 Million
Q3 2020

Nov 10, 2020

BUY
$454.43 - $535.6 $114,516 - $134,971
252 Added 7.04%
3,834 $1.98 Million
Q2 2020

Aug 12, 2020

BUY
$334.87 - $493.06 $379,742 - $559,130
1,134 Added 46.32%
3,582 $1.62 Million
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $892,827 - $1.14 Million
-2,790 Reduced 53.26%
2,448 $858,000
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $1.67 Million - $1.96 Million
5,238 New
5,238 $1.94 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.